ASGPR siRNA (Brilliant)

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameASGPR siRNA (Brilliant)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAsialoglycoprotein receptor binders
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsEndocrine System DiseasesMetabolic DiseasesCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Brilliant Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Brilliant Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEndocrine System DiseasesMetabolic DiseasesCardiovascular Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A